TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $284,000 | -27.6% | 5,939 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $392,000 | -14.6% | 5,894 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $459,000 | -17.6% | 5,894 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $557,000 | -22.5% | 5,894 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $719,000 | +40.2% | 5,894 | +0.3% | 0.00% | +50.0% |
Q3 2020 | $513,000 | +35.0% | 5,878 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $380,000 | +44.5% | 5,878 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $263,000 | -28.1% | 5,878 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $366,000 | +66.4% | 5,878 | +0.5% | 0.00% | +100.0% |
Q3 2019 | $220,000 | -7.6% | 5,850 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $238,000 | – | 5,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |